English
Home > Products > 50-07-7

China 50-07-7 Factory

We purpose to understand high quality disfigurement with the output and supply the top service to domestic and overseas buyers wholeheartedly for 50-07-7,CAS NO 50-07-7,Mitomycin API,Mitomycin C,Mitomycin, For more info, be sure to call us as shortly as possible!
50-07-7, Facing fierce global market competition, we have launched the brand building strategy and updated the spirit of ""human-oriented and faithful service"", with an aim to gain global recognition and sustainable development.

Related Products

Hot Products

  • (S)-2-Benzylsuccinic acid

    (S)-2-Benzylsuccinic acid

    Product Name:(S)-2-Benzylsuccinic acid
    Molecular Formula:C11H12O4
    Molecular Weight:208.21
    CAS Registry Number:3972-36-9
  • Lumateperone

    Lumateperone

    Product Name:Lumateperone
    Molecular Formula:C24H28FN3O
    Molecular Weight:393.5
    CAS Registry Number;313368-91-1
  • 3-Chloro-D-alanine methyl ester HCl

    3-Chloro-D-alanine methyl ester HCl

    Product Name:3-Chloro-D-alanine methyl ester HCl
    Molecular Formula:C4H9Cl2NO2
    Molecular Weight:174.03
    CAS Registry Number:112346-82-4
  • Ensitrelvir fumarate

    Ensitrelvir fumarate

    Product Name:Ensitrelvir fumarate
    Molecular Formula:C26H21ClF3N9O6
    Molecular Weight:647.96
    CAS Registry Number;2757470-18-9
  • (5-(4-Fluorophenyl)thiophen-2-yl)(5-iodo-2-Methylphenyl)Methanone

    (5-(4-Fluorophenyl)thiophen-2-yl)(5-iodo-2-Methylphenyl)Methanone

    Product Name:(5-(4-Fluorophenyl)thiophen-2-yl)(5-iodo-2-Methylphenyl)Methanone
    Molecular Formula:C18H12FIOS
    Molecular Weight:422.26
    CAS Registry Number:1071929-08-2
  • Salidroside

    Salidroside

    Product Name:Salidroside
    Molecular Formula:C14H20O7
    Molecular Weight:300.3
    CAS Registry Number:10338-51-9
  • Related Blog
  • Reviews

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 50-07-7

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept